Global Celiac Disease Market Research and Forecast 2018-2023

  • ID: 4537367
  • Report
  • Region: Global
  • Orion Market Research Private Limited
15 % OFF
until Jul 31st 2018
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • Adma Biologics, Inc.
  • Bayer Ag
  • Bristol-Myers Squibb
  • Chemocentryx Inc
  • Immusant, Inc.
  • MORE
Celiac disease market is an autoimmune disorder caused by the exposure to dietary gluten and damage inner lining of the small intestine. The disease can contribute to several diseases and disorders such as neurological disorder, infertility, low bone density, and certain cancers. There are presently no drugs available for the treatment of celiac disease. It can only be treated by consuming gluten-free diet. The expected launch of Alba/Teva’s larazotide acetate in the US in 2018 and in 5EU in 2019, and the launch of Alvine/AbbVie’s latiglutenase in the US in 2019 and in 5EU in 2020 are considered to fuel the market growth in the celiac disease market. These drugs are anticipated to target patients who undergo gluten exposure.

One of the major factors that is contributing in the market growth is organization of various awareness programs and initiatives taken by the government in different countries for the treatment of celiac disease. The government with such initiatives could strongly boost the market growth. In addition, various funds are offered to research and development activities that is further accelerating the market growth. For example, in Italy, children and adults are tested for celiac disease when they have specific symptoms. Vouchers are given to the diagnosed celiacs for buying specifically produced gluten free foods, up to $168 per month. Moreover, the Italian Celiac Association and government educates restaurants on how to deal with celiac disease. There are even gluten-free meals provided in hospitals, schools, and all other public eating establishments.

The global celiac disease market is analysed on the basis of geographical regions that are contributing significantly to the growth of the market. North America is estimated to be the dominating region in the global celiac disease market. Increasing patient pool in the region owing to increase in consumption of gluten-containing food is one of the major factors that is accelerating the growth of the market in North America.

The companies present actively in the global celiac disease market are Abbott Laboratories, Eli Lilly & Co, Novartis AG, Johnson & Johnson, Alvine Pharmaceuticals Inc., and so on.

Research Methodology:

The market study of celiac disease market is incorporated by extensive primary and secondary research conducted by research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The OMR team collects facts and data related to the market from different geographies to provide a better regional outlook. In the report, country level analysis is provided by analysing various regional players, regional tax laws and policies, consumer behaviour and macro-economic factors. The numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analysts to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts to get first-hand information. Primary research brings authenticity to our reports.

Secondary sources include:
  • Financial reports of companies involved in the market
  • Whitepapers, research-papers and news blogs
  • Company websites and their product catalogue
  • Supplier Websites such as Alibaba, amazon for pricing analysis
The report is intended for hospitals, diagnostics laboratories and research institutes for overall market analysis and competitive analysis. The report provides in-depth analysis on pricing, market size, and intended quality of the product preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models delivering insights into the market for better business decisions.

Market Segmentation:
1. Global celiac disease market by diagnostic type
2. Global celiac disease market by end users

The Report covers:
  • Comprehensive Research Methodology of Global Celiac Disease Market.
  • This report also includes detailed and extensive market overview with Analyst insights & key market trends.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Global Celiac Disease Market.
  • Insights about market determinants which are stimulating the Global Celiac Disease Market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • Adma Biologics, Inc.
  • Bayer Ag
  • Bristol-Myers Squibb
  • Chemocentryx Inc
  • Immusant, Inc.
  • MORE
Chapter 1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders

Chapter 2. Market Overview and Insights
2.1. Definition
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendation
2.2.3. Conclusion
2.3. Regulations
2.3.1.1. United States
2.3.1.2. European Union
2.3.1.3. China
2.3.1.4. India

Chapter 3. Market Determinants
3.1. Motivators
3.1.1. Prevalence of Celiac Diseases
3.1.2. Government Initiatives and Awareness ProgrAMS Such as Celiac Disease Awareness Campaign and Celiac Disease Screening Program
3.1.3. Inorganic Growth Strategies Such as Merger & Acquisition
3.1.4. High Consumption of Gluten-Containing Food Such as Bread, Coke, Beer and Pizza.
3.1.5. Rising Healthcare Expenditure in Developed Regions
3.2. Restraint
3.2.1. High Cost of Gluten-Free Food
3.2.2. Gluten Free Diet Being the Only Treatment Method Available
3.3. Opportunity
3.3.1. Robust Pipeline For Celiac Disease Drugs

Chapter 4. Market Segmentation
4.1. Global Celiac Disease Market By Diagnostic Type
4.1.1. Serologic Test
4.1.2. Genetic Testing
4.1.3. Small-Bowel Biopsy
4.2. Global Celiac Disease Market By End Users
4.2.1. Hospitals and Diagnostic Centers
4.2.2. Research Institutes

Chapter 5. Competitive Landscape
5.1. Market Strategy Analysis
5.2. Key Company Analysis
5.3. Pipeline Analysis

Chapter 6. Regional Analysis
6.1. North American
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. U.K
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. ROE
6.3. Asia Pacific
6.3.1. India
6.3.2. China
6.3.3. Japan
6.3.4. ROAPAC
6.4. Rest of the World

Chapter 7. Company Profiles
7.1. Abbott Laboratories, Inc.
7.2. Abbvie Inc.
7.3. Actogenix N.V.
7.4. Adma Biologics, Inc.
7.5. Alba Therapeutics Corporation
7.6. Alvine Pharmaceuticals, Inc.
7.7. Amgen Inc
7.8. Avaxia Biologics, Inc.
7.9. Bayer Ag
7.10. Bio Rad Laboratories Inc.
7.11. Biolinerx Ltd
7.12. Bristol-Myers Squibb
7.13. Btg Plc
7.14. Celgene Corporation
7.15. Chemocentryx Inc
7.16. Eli Lilly and Company
7.17. Glaxosmithkline Plc
7.18. Immusant, Inc.
7.19. Janssen Pharmaceuticals
7.20. Johnson & Johnson
7.21. Merck & Co Inc (Merck Sharp & Dohme Corp)
7.22. Sanofi S.A
7.23. Thermo Fisher Scientific, Inc

List of Tables:
Table 1 Global Celiac Disease Market Research and Analysis By Diagnostic Type, 2017-2023 ($ Million)
Table 2 Global Serologic Test Market Research and Analysis, 2017-2023 ($ Million)
Table 3 Global Genetic Testing Market Research and Analysis, 2017-2023 ($ Million)
Table 4 Global Celiac Disease Market Research and Analysis By End Users, 2017-2023 ($ Million)
Table 5 Global Hospitals and Diagnostic Centers Market Research and Analysis By, 2017-2023 ($ Million)
Table 6 Global Research Institutes Market Research and Analysis, 2017-2023 ($ Million)
Table 7 North American Celiac Disease Market Research and Analysis By Country, 2017-2023 ($ Million)
Table 8 North American Celiac Disease Market Research and Analysis By Diagnostic Type, 2017-2023 ($ Million)
Table 9 North American Celiac Disease Market Research and Analysis By End Users, 2017-2023 ($ Million)
Table 10 European Celiac Disease Market Research and Analysis By Country, 2017-2023 ($ Million)
Table 11 European Celiac Disease Market Research and Analysis By Diagnostic Type, 2017-2023 ($ Million)
Table 12 European Celiac Disease Market Research and Analysis By End Users, 2017-2023 ($ Million)
Table 13 APAC Celiac Disease Market Research and Analysis By Country, 2017-2023 ($ Million)
Table 14 APAC Celiac Disease Market Research and Analysis By Diagnostic Type, 2017-2023 ($ Million)
Table 15 APAC Celiac Disease Market Research and Analysis By End Users, 2017-2023 ($ Million)
Table 16 RoW Celiac Disease Market Research and Analysis By Diagnostic Type, 2017-2023 ($ Million)
Table 17 RoW Celiac Disease Market Research and Analysis By End Users, 2017-2023 ($ Million)

List of Figures:
Figure 1 Global Celiac Disease Market Share By Diagnostic Type, 2017 Vs 2023 (%)
Figure 2 Global Celiac Disease Market Share By End Users, 2017 Vs 2023 (%)
Figure 3 Global Celiac Disease Market Share By Geography, 2017 Vs 2023 (%)
Figure 4 North America Celiac Disease Market Size, 2017-2023 ($ Million)
Figure 5 Us Celiac Disease Market Size, 2017-2023 ($ Million)
Figure 6 Canada Celiac Disease Market Size, 2017-2023 ($ Million)
Figure 7 European Celiac Disease Market Size, 2017-2023 (4Million)
Figure 8 UK Celiac Disease Market Size, 2017-2023 ($ Million)
Figure 9 France Celiac Disease Market Size, 2017-2023 ($ Million)
Figure 10 Germany Celiac Disease Market Size, 2017-2023 ($ Million)
Figure 11 Italy Celiac Disease Market Size, 2017-2023 ($ Million)
Figure 12 Spain Celiac Disease Market Size, 2017-2023 ($ Million)
Figure 13 ROE Celiac Disease Market Size, 2017-2023 ($ Million)
Figure 14 Asia Pacific Celiac Disease Market Size, 2017-2023 ($Million)
Figure 15 India Celiac Disease Market Size, 2017-2023 ($ Million)
Figure 16 China Celiac Disease Market Size, 2017-2023 ($ Million)
Figure 17 Japan Celiac Disease Market Size, 2017-2023 ($ Million)
Figure 18 ROAPAC Celiac Disease Market Size, 2017-2023 ($ Million)
Figure 19 Rest of the World Celiac Disease Market Size, 2017-2023 ($ Million)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Laboratories, Inc.
  • Abbvie Inc.
  • Actogenix N.V.
  • Adma Biologics, Inc.
  • Alba Therapeutics Corporation
  • Alvine Pharmaceuticals, Inc.
  • Amgen Inc
  • Avaxia Biologics, Inc.
  • Bayer Ag
  • Bio Rad Laboratories Inc.
  • Biolinerx Ltd
  • Bristol-Myers Squibb
  • Btg Plc
  • Celgene Corporation
  • Chemocentryx Inc
  • Eli Lilly And Company
  • Glaxosmithkline Plc
  • Immusant, Inc.
  • Janssen Pharmaceuticals
  • Johnson & Johnson
  • Merck & Co Inc (Merck Sharp & Dohme Corp)
  • Sanofi S.A
  • Thermo Fisher Scientific, Inc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll